---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-088503"
form_type: "8-K"
ticker: null
cik: "0001463361"
company_name: "Unity Biotechnology, Inc."
filed_at: "2025-06-20T23:59:59+00:00"
generated_at: "2026-05-19T01:11:21.919036+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Unity Bio receives Nasdaq deficiency notice for bid price and equity; shares below $1.00

## Summary
- Closing bid price below $1.00 for 30 consecutive business days; 180-day cure period until Dec 15, 2025.
- Previously (Mar 2025) notified for equity below $10M minimum for Nasdaq Global Select; compliance plan submitted.
- Company applied to transfer to Nasdaq Capital Market on June 9, 2025.
- Failure to regain compliance may result in delisting; no assurance of cure.

## SEC filing metadata
- accession: 0000950170-25-088503
- form_type: 8-K
- cik: 0001463361
- company_name: Unity Biotechnology, Inc.
- filed_at: 2025-06-20T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1463361/000095017025088503/0000950170-25-088503-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1463361/000095017025088503/ubx-20250618.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-088503
- JSON: https://secwatch.observer/filing/0000950170-25-088503.json
- Plain text: https://secwatch.observer/filing/0000950170-25-088503.txt

## Key facts
- Listing & Compliance Notices
  Unity Biotechnology, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1), 5810(c)(3)(A)
  source text: June 18, 2025, Unity Biotechnology, Inc. (the “Company”) received a notification from The Nasdaq Stock Market (“Nasdaq”) that for the last 30 consecutive business days, the closing bid price of the Company’s common stock was below $1.00 per share, which is the minimum required closing bid price for continued listing on the Nasdaq Global Select Market pursuant to Listing Rule 5450(a)(1). This notice has no immediate effect on the Company’s Nasdaq listing or trading of its common stock. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days, or until December 15
  evidence_url: https://www.sec.gov/Archives/edgar/data/1463361/000095017025088503/0000950170-25-088503-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.